Rittenhouse Ventures, an experienced venture capital firm, has successfully closed Fund III, increasing its assets under management to over $75 million. The new fund will focus on investing in capital-efficient B2B software, artificial intelligence (AI), and tech-enabled services companies, with a strategic emphasis on the Mid-Atlantic and other underserved regions across the United States.
Building on a track record of over 15 years backing early-stage software founders, Fund III aligns with Rittenhouse Ventures’ commitment to partnering with emerging leaders in the software industry. “We are thrilled to be able to continue to back world-class management teams who have been able to scale their businesses through up and down markets, and navigate the challenges of building early-stage companies into category leaders,” stated Saul Richter, Founder & Managing Partner.
The investment philosophy for Fund III mirrors that of prior funds, targeting companies that demonstrate capital-efficient growth and potential for market leadership. Portfolio companies benefit from Rittenhouse Ventures’ operational expertise, extensive network access, and strategic guidance designed to accelerate scalable growth. The firm’s history includes over 30 portfolio investments and 20 exits, with notable investments such as Tabula Rasa HealthCare (NASDAQ: TRHC), AppsFlyer, Prosperoware (acquired by Litera), GSI Health (acquired by Medecision), Piano Software, and Halfpenny Technologies (acquired by Accumen).
Rittenhouse Ventures has cultivated significant domain expertise in Healthcare IT, with nearly half of its prior investments and deployed capital concentrated in this sector. This specialized vertical experience enhances the firm’s ability to identify and support high-potential companies within this strategic area.
A key development for Fund III is the addition of two seasoned partners: David Nevas and Sushma Rajagopalan. David Nevas brings nearly 20 years of technology investing experience, most recently serving as a Partner at Edison Partners. Sushma Rajagopalan contributes more than 30 years of operating leadership in the technology sector, having previously held roles as CEO of ITC Infotech and a Partner at LiquidHub. Their inclusion is expected to significantly strengthen Rittenhouse Ventures’ capabilities in sourcing, scaling, and successfully exiting high-potential companies.
Fund III has already commenced deploying capital, making initial investments in four portfolio companies: GoMo Health, Pieces Technologies, WealthHub Solutions, and High QA. The fund is actively seeking new, high-potential businesses for investment. Rittenhouse Ventures typically invests in companies generating between $2 million and $10 million in revenue, with investment rounds generally totaling $5 million or less.
